3 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Clopidogrel Tablets: new trials by email Literature Review of Clopidogrel Tablets trials Research Report on Clopidogrel Tablets
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetic/Pharmacodynamic Study of Vicagrel Capsules and Clopidogrel Tablets in Healthy CYP2C19 Normal Metabolizers Vicagrel Capsules, Clopidogrel Tablets - Acute Coronary Syndrome | Phase 1 | Completed | Jiangsu vcare pharmaceutical technology co., LTD | 18 | 2025-08-05 | 2025-09-09 |
| PK/PD Study of Vicagrel and Clopidogrel in Healthy Subjects With Different CYP2C19 Metabolizers vicagrel Capsules, Clopidogrel Tablets - Acute Coronary Syndrome | Phase 1 | Completed | Jiangsu vcare pharmaceutical technology co., LTD | 128 | 2021-12-09 | 2023-11-03 |
| PTRG-DES Consortium Clopidogrel Tablets - Coronary Artery Disease, Clopidogrel, Poor Metabolism of | Completed | Gyeongsang National University Hospital | 13160 | 2003-07-09 | 2022-03-31 |
Acute Coronary Syndrome (2) · Coronary Artery Disease (1) · Inflammation (1)
Jiangsu vcare pharmaceutical technology co., LTD (2) · Gyeongsang National University Hospital (1)
China (2) · South Korea (1) · United States (1)
Do-Sun Lim, MD, PhD (1) · Martin Kankam, MD (1) · Xiaojiao Li (1) · Yanhua Ding (1) · Youngjun David Kim, MD (1)
PMID 33171520, PMID 35512743, PMID 36423968, PMID 37045504, PMID 37119080, PMID 37679760, PMID 38177178, PMID 38258362, PMID 38463677, PMID 38740817, PMID 38761068, PMID 39552592, PMID 40977391, PMID 42047190, PMID 42461258